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Background: This study was performed to assess the value of procalcitonin (PCT) for the differential diagnosis
between infectious and non-infectious systemic inflammatory response syndrome (SIRS) after cardiac surgery.
Methods: Patients diagnosed with SIRS after cardiac surgery between April 1, 2011 and March 31, 2013 were
retrospectively studied. A total of 142 patients with SIRS, infectious (n = 47) or non-infectious (n = 95), were included. The
patients with infectious SIRS included 11 with sepsis, 12 with severe sepsis without shock, and 24 with septic shock.
Results: PCT, C-reactive protein (CRP), and the white blood cell (WBC) count were significantly higher in the infectious
SIRS group than in the non-infectious SIRS group. PCT had the highest sensitivity and specificity for differential diagnosis,
with a cut-off value for infectious SIRS of 0.47 ng/mL. PCT was more reliable than CRP in diagnosing severe sepsis without
shock, but it was not useful for diagnosing septic shock. The PCT cut-off value for diagnosing severe sepsis without shock
was 2.28 ng/mL.
Conclusions: PCT was a useful marker for the diagnosis of infectious SIRS after cardiac surgery. The optimal PCT cut-off
value for diagnosing infectious SIRS was 0.47 ng/mL.
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According to an epidemiological survey, the incidence
of sepsis in the USA rose at an average annual rate of
8.7% from 1979 to 2000 [1]. Sepsis and sepsis-related
complications are the main causes of death in intensive
care unit (ICUs). Of the approximately 750,000 patients
with severe systemic infection reported every year in the
USA, about 500 ultimately die of systemic infection and
its complications [2]. Post-cardiac surgery patients make
up a large proportion of patients treated in ICUs, and the
incidence of systemic infections is high among them.
According to one study, cardiac surgery has a mortality
of 8.5% with infection and 2.2% without infection [3].
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unless otherwise stated.will significantly improve the prognosis and avoid the
unnecessary use of antibiotics for patients without infections
[4]. It can still be very challenging, however, to reach
an early differential diagnosis of infectious systemic
inflammatory response syndrome (SIRS) based on clinical
manifestations alone. Recent studies have shown a signifi-
cant correlation of procalcitonin (PCT) with infection and
suggest that PCT is useful for the early diagnosis of
systemic infection [5,6]. In the present study, we evaluated
the differential diagnostic value of PCT for infectious SIRS
after cardiac surgery and compared PCT with the two
most traditional markers of infection, the C-reactive
protein (CRP) and white blood cell (WBC).Methods
This study was a retrospective investigation of 142 SIRS
patients who were admitted to the ICU after cardiac
surgery at the Tokyo Medical and Dental Universitytd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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when a total of 376 patients after cardiac surgery
were screened. The study was approved by the ethical
review board of Tokyo Medical and Dental University
Faculty of Medicine. The SIRS patients were divided
into an infectious SIRS group and a non-infectious
SIRS group according to the results of microbiological
testing. The infectious SIRS group was further divided
into three groups, namely, sepsis, severe sepsis without
shock, and septic shock, according to the diagnostic
criteria of the Surviving Sepsis Campaign Guidelines
for Management of Severe Sepsis and Septic Shock:
2012 (SSCG2012) [7].
The pre-operation data, operation-related data, and
post-operation data of both groups were analyzed and
compared. The pre-operation data included the patient
age, gender, body mass index (BMI), and concomitant
diseases. The operation-related data included the cardio-
pulmonary bypass (CPB) duration, aortic cross clamping,
operation time, and blood loss. The post-operation data
were as follows: mechanical ventilation (MV) duration,
disseminated intravascular coagulation (DIC) incidence,
serum levels of PCT, CRP, and WBC, Acute Physiology and
Chronic Health Evaluation (APACHE) II score, Sequential
Organ Failure Assessment (SOFA) score, ICU stay, hospital
stay, postoperative blood purification treatment ratio such
as continuous renal replacement therapy (CRRT) and
polymyxin B-immobilized fiber column-direct hemo-
perfusion (PMX-DHP), and postoperative extracorpor-
eal membrane oxygenation (ECMO) therapy. DIC was
identified using a score based on platelet count
(>100 × 103/μL = 0; <100 × 103/μL = 1; <50 × 103/μL = 2),
elevated fibrin-related marker (e.g., soluble fibrin mono-
mers or fibrin degradation products, no increase: 0;
moderate increase: 2; strong increase: 3), prolonged
prothrombin time (<3 s = 0; >3 but <6 s = 1; >6 s = 2),
and fibrinogen level (>1.0 g/L = 0; <1.0 g/L = 1) derived
from the International Society on Thrombosis and
Haemostasis [8]. The total score of the four parameters ≥5
is compatible with overt DIC.
The APACHE II score and SOFA score were determined
within the first 24 h from admission to the ICU. The
PCT, CRP, and WBC measurements were conducted
by a hospital test cabinet. The serum PCT level was
determined with a ‘Cobas 6000’ analyzer (Roche; detection
sensitivity of 0.05 ng/mL). The serum CRP level was
determined by a latex coagulation detection method
with a nephelometer. The PCT, CRP, and WBC levels
measured on the first day after the diagnosis of SIRS
in the ICU were used in this analysis.
Statistical analysis
Statistical analyses were performed using a Statistical
Package for Social Sciences (SPSS 17.0 Inc., Chicago, IL,USA) for Windows. For the numerical data, the homo-
geneity test of variance was done first. If the variance
was homogeneous, the data were shown as mean ± SD.
The numerical data comparisons between two groups
were analyzed by the two-sided Student’s t test and
comparisons of more than two groups were analyzed
by the one-way analysis of variance test. If the variance was
not homogeneous, the data were shown in median and
interquartile ranges. Comparisons between two groups
were done by the Mann-Whitney test and comparisons of
more than two groups were done by the Kruskal-Wallis
test. The categorical data comparisons between groups
were analyzed by the Pearson Chi-square test or Fisher’s
exact test. Statistical significance was assumed at p values
of less than 0.05 on both sides. The abilities of PCT,
WBC, and CRP to diagnose infection were evaluated
by comparing the infectious and non-infectious groups by
receiver operating characteristic (ROC) curve analyses.
The abilities of PCT and CRP to diagnose severe sep-
sis without shock or septic shock were evaluated by
ROC curve analyses comparing the sepsis group with
the severe sepsis without shock/septic shock groups
and comparing the severe sepsis without shock group
with the septic shock group. The cut-off values for
diagnosing infection, severe sepsis without shock,
and septic shock were determined by the ROC
curves. The diagnosis sensitivity, specificity, and posi-
tive and negative predictive values were calculated
and compared.
Results
The characteristics of the infectious SIRS group and
non-infectious SIRS group
In total, 142 patients were treated for SIRS after cardiac
surgery. Among them, 47 were diagnosed with infectious
SIRS and 95 were diagnosed with non-infectious SIRS.
Table 1 shows the patients’ characteristics of the two
groups. There were no significant differences between
the two groups in age, gender, body mass index, CPB
duration, aortic cross clamping, operative time, operative
mortality, or blood loss. The hospital mortality, APACHE II
score, SOFA score, MV duration, postoperative blood
purification treatment ratio, postoperative extracor-
poreal membrane oxygenation (ECMO) therapy, DIC
incidence, ICU stay, and hospital stay were signifi-
cantly higher in the infectious SIRS group than in the
non-infectious SIRS group. Three patients in the infec-
tious SIRS group died of septic shock within 30 days after
the operation, and another 19 patients died of septic shock
30 days after the operation during the hospital stay.
The operative mortality and hospital mortality of the
infectious SIRS group were 6.38% and 46.8%, respect-
ively. Three patients in the infectious SIRS group were
complicated with cerebral hemorrhage, and one was
Table 1 The comparison between the infectious and non-infectious groups
Infectious SIRS (n = 47) Non-infectious SIRS (n = 95) p value
Age (year) 67.8 ± 15.7 67.2 ± 13.3 0.81
Gender, n (%) 0.77
Male 32 (68.1) 67 (70.5)
Female 15 (31.9) 28 (29.5)
Type of surgery, n (%)
Valve surgery 16 (34.0) 36 (37.9) 0.65
CABG 9 (19.1) 11 (11.6) 0.22
Vessel replacement 13 (27.7) 21 (22.7) 0.47
VAD 3 (6.4) 1 (1.1) 0.11
Interventional therapy 1 (2.1) 14 (14.7) 0.02
Complex surgery 5 (10.6) 12 (12.6) 0.73
BMI, kg/m2 21.8 (20.0,26.7) 22.7 (20.4,24.7) 0.64
Concomitant disease, n (%)
Diabetes mellitus 18 (38.3) 25 (26.3) 0.14
Hypertension 20 (42.6) 35 (36.8) 0.51
CKD 19 (40.4) 21 (22.1) 0.02
CPB duration, min 197.2 ± 142.5 173.6 ± 123.5 0.31
Aortic cross clamping, min 99.0 ± 100.1 98.3 ± 84.7 0.96
Operation time, min 508.9 ± 192.4 466.3 ± 174.9 0.19
Blood loss, mL 3,512 ± 3,150 3,189 ± 2,706 0.53
APACHE II 19.0 (15.0,25.0) 11.0 (9.0,14.0) 0.001
SOFA 7.0 ± 2.6 5.1 ± 2.1 0.001
PCT, ng/mL 2.80 (1.24,10.20) 0.10 (0.06,0.21) 0.001
WBC, ×103/μL 15.5 (11.0,22.6) 9.3 (7.2,12.6) 0.001
CRP, mg/dL 15.8 (12.0,19.9) 5.8 (2.5,8.9) 0.001
ICU stay, day 23.0 (12.0,52.0) 5.0 (3.0,6.0) 0.001
Hospital stay, day 82.0 (37.0,149.0) 31.0 (23.0,45.0) 0.001
MV duration, h 264.0 (40.0,999.0) 17.0 (10.0,39.0) 0.001
CRRT, n (%) 26 (55.3) 5 (5.3) 0.001
PMX-DHP, n (%) 18 (38.3) 0 0.001
ECMO, n (%) 13 (27.7) 0 0.001
DIC, n (%) 23 (48.9) 0 0.001
30-Day mortality, n (%) 3 (6.38) 0 0.035
Hospital mortality, n (%) 22 (46.8) 0 0.001
CABG coronary artery bypass graft, VAD ventricular assist device, BMI body mass index, CKD chronic kidney disease, CPB cardiopulmonary bypass, APACHE II acute
physiology and chronic health evaluation II, SOFA sequential organ failure assessment, MV mechanical ventilation, CRRT continuous renal replacement therapy,
PMX-DHP polymyxin B-immobilized fiber column direct hemoperfusion, ECMO extracorporeal membrane oxygenation, DIC disseminated intravascular coagulation.
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during the hospital stay in the non-infectious SIRS
group.
The infectious pathogens were Gram-positive bac-
teria in 19 patients, Gram-negative bacteria in 14
patients, and fungus in 16 patients. The positive culture
specimens were sputum in 14, urine in 15, blood in 24,
and drainage in 1.The differential diagnostic values of PCT for infectious
and non-infectious SIRS
PCT, CRP, and WBC levels were significantly higher in
the infectious SIRS group than in the non-infectious
SIRS group (Table 1). Preoperative chronic kidney
disease (CKD), APACHE II and SOFA scores, ICU and
hospital stay, MV duration, CRRT, PMX-DHP, ECMO
therapy, DIC incidence, 30-day mortality, and hospital
Zhao et al. Journal of Intensive Care 2014, 2:35 Page 4 of 7
http://www.jintensivecare.com/content/2/1/35mortality were significantly higher in the infectious SIRS
group than in the non-infectious SIRS group (Table 1).
The ROC curves of PCT, CRP, and WBC for infectious
SIRS are shown in Figure 1. The areas under the curve
(AUCROC) were 0.966, 0.875, and 0.799 for PCT, CRP, and
WBC, respectively. According to the ROC curves, the
cut-off values of PCT, CRP, and WBC were 0.47 ng/mL,
11.95 mg/dL, and 10.85 × 103/μL, respectively. The sensi-
tivity and specificity of PCT for predicting infection were
91.5% and 93.7%, respectively.
Infection subgroup analysis
According to the diagnostic criteria, 47 patients from
the infectious group were further divided into sepsis
(n = 11), severe sepsis without shock (n = 12), and septic
shock (n = 24). The patient characteristics of the three
subgroups are shown in Table 2. No significant difference
in WBC counts was found among the three subgroups,
but the levels of PCT and CRP were significantly different.
Preoperative CKD, CPB duration, APACHE II and SOFA
scores, ICU and hospital stay, MV duration, CRRT,
PMX-DHP, ECMO therapy, DIC incidence, and positive
rate of MRSA culture were significantly higher in the
septic shock subgroup than in the other two groups.
Differential diagnostic values of PCT for the severity of
sepsis
The ROC curves of PCT and CRP for diagnosing severe
sepsis without shock and septic shock are shown in
Figure 2. PCT could be used for diagnosing severe sepsis
without shock with a larger AUC than CRP. PCT was
not useful, however, for diagnosing septic shock. TheFigure 1 The ROC curves of PCT, CRP, and WBC for
predicting infection.PCT cut-off value for diagnosing severe sepsis without
shock was 2.28 ng/mL, with a sensitivity and specificity
of 66.7% and 90.9%, respectively. The positive predictive
value and negative predictive value of PCT for severe
sepsis without shock were 96.0% and 45.5%, respectively.
The cut-off value of CRP for diagnosing septic shock
was 14.95 mg/dL, with a sensitivity and specificity of
83.3% and 66.7%, respectively. The positive predictive
value and negative predictive value of CRP for septic
shock were 87.0% and 69.2%, respectively.
Discussion
PCT is a calcitonin precursor with 116 amino acids, no
hormonal activity, and a relative molecular weight of
13,000. PCT is mainly secreted by the thyroid C-cells
and peripheral mononuclear cells and has a half-life of
about 24 h. PCT levels are extremely low and often difficult
to detect in healthy people. At the time of infection, a bac-
terial component such as lipopolysaccharide or a cytokine
such as tumor necrosis factor-α (TNF-α) or interleukin-6
(IL-6) induces high expression of the calcitonin-I gene,
which activates the continuous release of PCT [9].
The surgical injury to the body and extracorporeal
circulation during cardiac surgery can activate the
complement system, which in turn induces the massive
release of inflammatory cytokines and the subsequent
onset of SIRS [10]. Once developed, SIRS goes on to cause
multiple tissue and organ dysfunction, leading to a variety
of postoperative complications [3]. Patients who elude
SIRS from operative injuries still face the risk of SIRS
induced by postoperative infection. Early diagnosis and
prompt treatment of infection significantly improve the
prognosis. Yet the differential diagnosis of infectious
and non-infectious SIRS from different causes is still
challenging. Some investigators have been convinced of
the diagnostic value of PCT for differentiating infectious
SIRS from non-infectious SIRS [11-14]. According to their
reports, PCT indicates infection more reliably than
traditional indicators such as body temperature, WBC,
CRP, or cytokines (IL-6, IL-8). Yet another study has con-
cluded that PCT was poor at distinguishing infectious
SIRS from non-infectious SIRS [15]. In the present study,
we found PCT to be useful in the diagnosis of infectious
SIRS after cardiac surgery, and to have a higher sensitivity
and specificity than any of the traditional markers. We
suspect that the discrepancies in the results on PCT
are linked to the many conditions that can affect
PCT secretion. Infection, surgery, trauma, and other
stress factors unrelated to infection can elevate PCT
levels to varying degrees. The patients studied have
also been quite heterogeneous; hence the PCT cut-off
values for diagnosis have varied widely based on different
diseases or different degrees of stress. As factors unrelated
to infection, the preoperative CKD may affect PCT levels
Table 2 The comparison of infectious subgroups
Sepsis (n = 11) Severe sepsis without shock (n = 12) Septic shock (n = 24) p value
Age (year) 70.6 ± 13.7 65.2 ± 19.0 67.8 ± 15.3 0.716
Gender, n (%) 0.058
Male 5 (45.5) 11 (91.7) 16 (66.7)
Female 6 (54.5) 1 (8.3) 8 (33.3)
BMI, kg/m2 21.6 (18.4,24.1) 20.6 (20.1,21.7) 23.9 (20.5,28.8) 0.090
Concomitant disease, n (%)
Diabetes mellitus 3 (27.3) 6 (50.0) 9 (37.5) 0.531
Hypertension 5 (45.5) 3 (25.0) 12 (50.0) 0.351
CKD 4 (36.4) 2 (16.7) 13 (54.2) 0.001
CPB duration, min 102.0 ± 129.4 187.5 ± 134.8 245.6 ± 133.4 0.017
Aortic cross clamping, min 69.4 ± 92.4 108.8 ± 84.2 107.8 ± 111.4 0.542
Operation time, min 418.5 ± 136.1 540.8 ± 121.7 534.5 ± 231.9 0.206
Blood loss, mL 802 (398,2489) 6790 (1364,8324) 2530 (1227,4961) 0.019
APACHE II 15.5 ± 6.1 16.8 ± 7.6 23.5 ± 6.2 0.002
SOFA 5.5 ± 1.4 5.9 ± 2.9 8.2 ± 2.5 0.004
ICU stay, day 12.0 (4.0,23.0) 13.0 (7.3,24.5) 49.5 (17.8,81) 0.001
Hospital stay, day 60.9 ± 59.6 114.2 ± 85.5 124.5 ± 101.0 0.152
30-Day mortality, n (%) 0 0 3 (12.5) 0.215
Hospital mortality, n (%) 0 0 22 (91.7) 0.001
MV duration, h 40.0 (16.0,183.0) 58.5 (13.5,404.3) 992.5 (276.3,1559.3) 0.001
CRRT, n (%) 3 (27.3) 2 (16.7) 21 (87.5) 0.001
PMX-DHP, n (%) 0 0 17 (70.8) 0.001
ECMO, n (%) 0 1 (8.3) 12 (50.0) 0.001
DIC, n (%) 0 1 (8.3) 22 (91.7) 0.024
PCT, ng/mL 1.37 (0.72,1.85) 3.16 (0.48,13.24) 3.68 (1.67,20.96) 0.024
WBC, ×103/μL 12.40 (9.10,24.20) 13.30 (9.93,16.93) 20.40 (13.45,28.6) 0.060
CRP, mg/dL 12.00 (7.40,18.00) 13.57 (8.17,18.13) 17.11 (15.15,30.6) 0.009
Gram positive, n (%)
MRSA 0 0 6 (25.0) 0.037
S. epidermidis 2 (18.7) 4 (33.3) 1 (4.2) 0.064
E. faecalia 0 0 3 (12.5) 0.215
C. striatum 0 0 3 (12.5) 0.215
Gram negative, n (%)
S. marcescens 0 2 (16.7) 2 (8.3) 0.359
P. aeruginosa 1 (9.1) 1 (8.3) 3 (12.5) 0.913
B. cepacia 1 (9.1) 1 (8.3) 1 (4.2) 0.815
K. pneumoniae 1 (9.1) 1 (8.3) 0 0.335
Candida, n (%)
C. albicans 4 (36.4) 2 (16.7) 3 (12.5) 0.242
C. glabrata 0 0 2 (8.3) 0.368
C. parapsilosis 0 1 (8.3) 1 (4.2) 0.613
C. tropicalis 1 (9.1) 1 (8.3) 1 (4.2) 0.815
MRSA methicillin-resistant Staphylococcus aureus; for other abbreviations, see Table 1.
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Figure 2 ROC curves of PCT and CRP for predicting (A) severe sepsis without shock and (B) septic shock.
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shown that using the threshold of 0.85 ng/mL PCT was a
strong independent predictor of infection [16], suggesting
that the PCT threshold was rising a little in CKD. On
the other hand, Maisner et al. have reported that PCT
levels were unchanged during CRRT in sepsis patients
with acute kidney injury, although elimination of PCT
depended on the duration of CRRT [17]. PMX-DHP may
also affect the PCT levels, since it adsorbs endotoxin
and decreases inflammation. However, PMX-DHP was not
started at the time of PCT measurement. Stress factors
such as ECMO therapy may affect PCT levels. Rungatscher
et al. have shown that high levels of PCT were associated
with multiple organ dysfunction syndrome in pediatric
patients with ECMO [18]. This finding is consistent with
our result that PCT levels increased in proportion to the
severity of sepsis and multiple organ dysfunction syn-
drome. Consequently, PCT levels in the infectious SIRS
group were significantly (p < 0.001) higher than those in
the non-infectious SIRS group. Therefore, PCT becomes a
tool to distinguish infectious and non-infectious SIRS,
although some factors such as CKD and multiple organ
dysfunction syndrome may affect the PCT level.
Clec’h et al. reported a wide variability of PCT cut-off
values in an analysis of 143 patients with different
diseases [19]. By their calculation, the optimal PCT cut-off
value for diagnosing infection in surgical patients was
9.7 ng/mL (sensitivity 91.7%, specificity 74.2%), whereas
the optimal PCT cut-off value for infection diagnosis
in non-surgical patients was 1.00 ng/mL (sensitivity
80%, specificity of 94%). Meisner et al. investigated
the correlations of operative techniques with the PCT
cut-off values. By their estimate, the optimal PCT
cut-off value in diagnosis of infection in patients after
cardiac surgery was 2.0 ng/mL [20]. In describing
PCT as a marker of infection, the aforesaid two studies
recommended that the cut-off value be set according to
the patient’s diagnosis and the type of surgery performed.
PCT had a better diagnostic value than CRP and WBC inthe present study. For the patients after cardiac surgery,
the optimal PCT cut-off value for diagnosing infectious
SIRS was 0.47 ng/mL. The sensitivity and specificity of
PCT for the differential diagnosis of infectious SIRS and
non-infectious SIRS at this cut-off (91.5% and 93.7%,
respectively) were significantly better than those of CRP
and WBC. When comparing the cut-off values, we should
consider both the primary disease and type of surgery, as
well as the time point of markers measurement.
The utility of PCT for evaluating infection severity has
also been controversial. One study suggested that the PCT
was a valuable parameter for determining infection, but
was no better than CRP in evaluating the infection severity
[21]. In contrast, Harbarth et al. found that serum PCT
concentrations increased in step with the severity of infec-
tion [11]. Our results, like those of Harbarth’s group, dem-
onstrated a rise in serum PCTconcentrations in association
with infection severity. The median PCT concentrations in
sepsis, severe sepsis without shock, and septic shock group
were 1.37, 3.16, and 3.68 ng/mL, respectively (Table 2).
PCT was a good marker of severe sepsis without shock
(cut-off value of 2.28 ng/mL), but it had no significant value
for diagnosing septic shock. This was consistent with the
study by Brunkhorst et al. [22].
The MV duration, postoperative blood purification
therapy, postoperative ECMO therapy, DIC incidence, ICU
stay, and hospital mortality were all significantly higher in
the infectious SIRS group than in the non-infectious SIRS
group. These findings indicate that infection will increase
the disease severity and necessitate more invasive treat-
ments such as MV, CRRT, and ECMO. This finding was
consistent with the results of Rahmanian et al. [23]. The
septic shock subgroup in the present study had more blood
infections, especially MRSA infections. This finding was
consistent with the study by Chen et al. [24].
There are three limitations to this study worthy of
note: The study was retrospective; the samples were too
small, especially for the infectious group; and no long-term
follow-up was performed.
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Infection after cardiac surgery significantly increased the
disease severity and necessitated more invasive treatments
such as mechanical ventilation, CRRT, and ECMO. PCT
was a useful marker for the diagnosis of infectious SIRS
after cardiac surgery. PCT had a better diagnostic value
than CRP or WBC. The optimal PCT cut-off value for
detecting infection was 0.47 ng/mL. The serum level of
PCT rose significantly according to the degree of infection.
Prospective, large-scale, controlled, and randomized
studies are awaited.
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